Effects of pitavastatin on atherosclerotic-associated inflammatory biomarkers in people living with HIV with dyslipidemia and receiving ritonavir-boosted atazanavir: a randomized, double-blind, crossover study

Effects of pitavastatin on atherosclerotic-associated inflammatory biomarkers in people living with HIV with dyslipidemia and receiving ritonavir-boosted atazanavir: a randomized, double-blind, crossover study

Abstract Background Chronic inflammation has been described in people living with HIV (PLHIV) receiving antiretroviral therapy (ART) despite viral suppression. Inflammation associated non-communicable diseases, including atherosclerosis, are becoming recognized complication of HIV infection. We stud...

Full description

Bibliographic Details
Main Authors: Sirawat Srichatrapimuk, Artit Wongsa, Somnuek Sungkanuparph, Sasisopin Kiertiburanakul, Boonrat Tassaneetrithep, Angsana Phuphuakrat
Format: Article
Language:English
Published: BMC 2023-02-01
Series:AIDS Research and Therapy
Subjects:
Atherosclerosis
Dyslipidemia
HIV infection
Inflammatory biomarker
Pitavastatin
Online Access:https://doi.org/10.1186/s12981-023-00506-2

Internet

https://doi.org/10.1186/s12981-023-00506-2

Similar Items